Recently, Kretzmann et al. [43] showed that inhibition of iNOS may contribute to the therapeutic effect of glutamine in rats with 2,4,6-trinitrobenzene sulfonic acid-induced colitis. The gene discussed is NOS2; the disease is colitis.